Biosensis' innovative Rapid ELISA range delivers fast, accurate, and reproducible analysis of key biomarkers associated with neurodegenerative diseases such as Alzheimer's Disease (AD) and Amyotrophic Lateral Sclerosis (ALS). These assays enable the detection of critical neurological proteins, including isoform-specific BDNF and NGF neurotrophins, as well as their receptors (p75NTR, TrkA, TrkB, and TrkC).
Our Mature and proBDNF Rapid ELISA kits are engineered for precision and reliability, offering the sensitivity needed to quantify each isoform independently. Our NGF ELISA kits are optimized for faster turnaround times and greater sensitivity, making them ideal for both high-throughput projects and detailed biomarker investigations. We also offer combination kits for added convenience and flexibility. This allows researchers to measure multiple targets in parallel, maximizing efficiency while reducing sample consumption.
All Biosensis kits undergo rigorous in-house validation to ensure dependable performance. Each kit arrives ready to use, with clear, detailed protocols to guide you through every step. Our streamlined workflows save valuable time and help ensure consistent and reproducible results.
